96 related articles for article (PubMed ID: 26731899)
21. Generation of a monoclonal antibody against the mouse Sf3b1 (SAP155) gene product for U2 snRNP component of spliceosome.
Horie A; Isono K; Koseki H
Hybrid Hybridomics; 2003 Apr; 22(2):117-9. PubMed ID: 12831537
[TBL] [Abstract][Full Text] [Related]
22. c-myc suppressor FBP-interacting repressor for cancer diagnosis and therapy.
Matsushita K; Tomonaga T; Kajiwara T; Shimada H; Itoga S; Hiwasa T; Kubo S; Ochiai T; Matsubara H; Nomura F
Front Biosci (Landmark Ed); 2009 Jan; 14(9):3401-8. PubMed ID: 19273283
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of far upstream element (FUSE) binding protein (FBP)-interacting repressor (FIR) supports growth of hepatocellular carcinoma.
Malz M; Bovet M; Samarin J; Rabenhorst U; Sticht C; Bissinger M; Roessler S; Bermejo JL; Renner M; Calvisi DF; Singer S; Ganzinger M; Weber A; Gretz N; Zörnig M; Schirmacher P; Breuhahn K
Hepatology; 2014 Oct; 60(4):1241-50. PubMed ID: 24824848
[TBL] [Abstract][Full Text] [Related]
24. Alternative splicing of the tumor suppressor ASPP2 results in a stress-inducible, oncogenic isoform prevalent in acute leukemia.
Schittenhelm MM; Walter B; Tsintari V; Federmann B; Bajrami Saipi M; Akmut F; Illing B; Mau-Holzmann U; Fend F; Lopez CD; Kampa-Schittenhelm KM
EBioMedicine; 2019 Apr; 42():340-351. PubMed ID: 30952616
[TBL] [Abstract][Full Text] [Related]
25. The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expression.
Liu J; Kouzine F; Nie Z; Chung HJ; Elisha-Feil Z; Weber A; Zhao K; Levens D
EMBO J; 2006 May; 25(10):2119-30. PubMed ID: 16628215
[TBL] [Abstract][Full Text] [Related]
26. SAP155 Binds to ceramide-responsive RNA cis-element 1 and regulates the alternative 5' splice site selection of Bcl-x pre-mRNA.
Massiello A; Roesser JR; Chalfant CE
FASEB J; 2006 Aug; 20(10):1680-2. PubMed ID: 16790528
[TBL] [Abstract][Full Text] [Related]
27. Splicing factor 3b subunit 1 (Sf3b1) haploinsufficient mice display features of low risk Myelodysplastic syndromes with ring sideroblasts.
Visconte V; Tabarroki A; Zhang L; Parker Y; Hasrouni E; Mahfouz R; Isono K; Koseki H; Sekeres MA; Saunthararajah Y; Barnard J; Lindner D; Rogers HJ; Tiu RV
J Hematol Oncol; 2014 Dec; 7():89. PubMed ID: 25481243
[TBL] [Abstract][Full Text] [Related]
28. Haploinsufficiency of Sf3b1 leads to compromised stem cell function but not to myelodysplasia.
Matsunawa M; Yamamoto R; Sanada M; Sato-Otsubo A; Shiozawa Y; Yoshida K; Otsu M; Shiraishi Y; Miyano S; Isono K; Koseki H; Nakauchi H; Ogawa S
Leukemia; 2014 Sep; 28(9):1844-50. PubMed ID: 24535406
[TBL] [Abstract][Full Text] [Related]
29. Molecular basis of FIR-mediated c-myc transcriptional control.
Cukier CD; Hollingworth D; Martin SR; Kelly G; Díaz-Moreno I; Ramos A
Nat Struct Mol Biol; 2010 Sep; 17(9):1058-64. PubMed ID: 20711187
[TBL] [Abstract][Full Text] [Related]
30. Molecular cloning, genetic mapping, and expression of the mouse Sf3b1 (SAP155) gene for the U2 snRNP component of spliceosome.
Isono K; Abe K; Tomaru Y; Okazaki Y; Hayashizaki Y; Koseki H
Mamm Genome; 2001 Mar; 12(3):192-8. PubMed ID: 11252167
[TBL] [Abstract][Full Text] [Related]
31. Acetylation of PHF5A Modulates Stress Responses and Colorectal Carcinogenesis through Alternative Splicing-Mediated Upregulation of KDM3A.
Wang Z; Yang X; Liu C; Li X; Zhang B; Wang B; Zhang Y; Song C; Zhang T; Liu M; Liu B; Ren M; Jiang H; Zou J; Liu X; Zhang H; Zhu WG; Yin Y; Zhang Z; Gu W; Luo J
Mol Cell; 2019 Jun; 74(6):1250-1263.e6. PubMed ID: 31054974
[TBL] [Abstract][Full Text] [Related]
32. Investigating the Molecular Mechanism of H3B-8800: A Splicing Modulator Inducing Preferential Lethality in Spliceosome-Mutant Cancers.
Spinello A; Borišek J; Malcovati L; Magistrato A
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681880
[TBL] [Abstract][Full Text] [Related]
33. Spliceosome mutations involving SRSF2, SF3B1, and U2AF35 in chronic myelomonocytic leukemia: prevalence, clinical correlates, and prognostic relevance.
Patnaik MM; Lasho TL; Finke CM; Hanson CA; Hodnefield JM; Knudson RA; Ketterling RP; Pardanani A; Tefferi A
Am J Hematol; 2013 Mar; 88(3):201-6. PubMed ID: 23335386
[TBL] [Abstract][Full Text] [Related]
34. Dimerization of FIR upon FUSE DNA binding suggests a mechanism of c-myc inhibition.
Crichlow GV; Zhou H; Hsiao HH; Frederick KB; Debrosse M; Yang Y; Folta-Stogniew EJ; Chung HJ; Fan C; De la Cruz EM; Levens D; Lolis E; Braddock D
EMBO J; 2008 Jan; 27(1):277-89. PubMed ID: 18059478
[TBL] [Abstract][Full Text] [Related]
35. The development and application of small molecule modulators of SF3b as therapeutic agents for cancer.
Webb TR; Joyner AS; Potter PM
Drug Discov Today; 2013 Jan; 18(1-2):43-9. PubMed ID: 22885522
[TBL] [Abstract][Full Text] [Related]
36. Gene therapy of c-myc suppressor FUSE-binding protein-interacting repressor by Sendai virus delivery prevents tracheal stenosis.
Mizokami D; Araki K; Tanaka N; Suzuki H; Tomifuji M; Yamashita T; Ueda Y; Shimada H; Matsushita K; Shiotani A
PLoS One; 2015; 10(1):e0116279. PubMed ID: 25569246
[TBL] [Abstract][Full Text] [Related]
37. Aberrant splicing in B-cell acute lymphoblastic leukemia.
Black KL; Naqvi AS; Asnani M; Hayer KE; Yang SY; Gillespie E; Bagashev A; Pillai V; Tasian SK; Gazzara MR; Carroll M; Taylor D; Lynch KW; Barash Y; Thomas-Tikhonenko A
Nucleic Acids Res; 2018 Nov; 46(21):11357-11369. PubMed ID: 30357359
[TBL] [Abstract][Full Text] [Related]
38. SF3B1 association with chromatin determines splicing outcomes.
Kfir N; Lev-Maor G; Glaich O; Alajem A; Datta A; Sze SK; Meshorer E; Ast G
Cell Rep; 2015 Apr; 11(4):618-29. PubMed ID: 25892229
[TBL] [Abstract][Full Text] [Related]
39. [Gene mutation and myelodysplastic syndromes with ring sideroblast excess].
Meng FK; Huang LF; Zhou JF; Sun HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1088-90. PubMed ID: 23998618
[TBL] [Abstract][Full Text] [Related]
40. Chronic lymphocytic leukemia with SF3B1 mutation.
Quesada V; Ramsay AJ; Lopez-Otin C
N Engl J Med; 2012 Jun; 366(26):2530. PubMed ID: 22738114
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
